284670-98-0: Sorafenib Inhouse Impurity E

Sorafenib Inhouse Impurity E (CAS No: 284670-98-0) Or N, N’-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, Sorafenib Inhouse Impurity E is an impurity of Sorafenib, Sorafenib is an orally active multikinase inhibitor, which is used for the treatment of renal cell carcinoma.

Additional information on CAS 284670-98-0

Catalogue No.

VE008168

CAS No.

284670-98-0

Molecular Formula

C27H24N6O5

Molecular Weight

512.52 g/mol

Parent drug

Sorafenib

IUPAC Name

N, N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea

Synonyms

N/A

References

Sci-Hub, Fragmentation pathways and differentiation of positional isomers of sorafenib and structural analogues by ESI-IT-MS n and ESI-Q-TOF-MS/MS coupled with DFT calculations, 10.1002/jms.4192. (2018). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1002/jms.4192

Status

In-stock

Request a quote

284670-98-0: Sorafenib Inhouse Impurity E

284670-98-0: Sorafenib Inhouse Impurity E
Catalogue No.

VE008168

CAS No.

284670-98-0

Molecular Formula

C27H24N6O5

Molecular Weight

512.52 g/mol

Parent drug

Sorafenib

IUPAC Name

N, N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea

Synonyms

N/A

References

Sci-Hub, Fragmentation pathways and differentiation of positional isomers of sorafenib and structural analogues by ESI-IT-MS n and ESI-Q-TOF-MS/MS coupled with DFT calculations, 10.1002/jms.4192. (2018). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1002/jms.4192

Status

In-stock

ListName

Sorafenib Inhouse Impurity E

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url